AdvancePharma Innovations

😲

The looming crisis of a silent epidemic. 🙋🏿‍♂️👇🏿
Why to for millions in is of extreme importance.

By 2030, the prevalence of chronic illnesses is expected to rise sharply in Africa. According to the World Health Organization (WHO), there will be 47 million people with diabetes alone by 2045, up from 19 million in 2019.
☄️🔥 Non-communicable diseases (NCDs) such as heart disease, cancer, and diabetes already account for a substantial portion of deaths in many African countries, ranging from 50% to 88%. There is a tremendous strain on the continent's healthcare systems due to young people taking medications every day for the rest of their lives.
🔕 The rise in chronic diseases in Africa is particularly alarming. For instance, the number of people living with diabetes is expected to more than double from 19 million in 2019 to 47 million by 2045, representing a staggering increase of over 150%. This means more medicines to be procured on a regular basis for longer periods.
💥 As of 2021, NCDs accounted for 45% of deaths in Ghana.As is the case with the rest of Africa, Ghana's chronic disease burden is expected to increase dramatically by 2030 and beyond. This is largely due to factors such as aging populations, urbanization, and changing lifestyles.
Approximately 25.1% of people living in urban areas are at higher risk of obesity, cardiovascular diseases, diabetes, and other NCDs.This translates to 5.2 million people in Ghana at risk of these diseases.
👩🏿‍⚕️ All these diseases have to be clinically managed for the rest of the life term of the patient.
Addressing the rising burden of chronic diseases in Africa requires strategic interventions. The most impactful challenge to address is access to medicines since all these diseases are managed on medications for life.

Happy Friday! 🎉 At AdvancePharma Innovations, we are dedicated to transforming healthcare through the power of technology and data. Visit our website to learn more about how we're making a difference: advancepharmainnovations.com.
🌍✨

4 years ago, I set out on an ambitious project to innovate a new payment system for the pharmaceutical sector due to its unique challenges. TODAY MARKS THE INAUGRATION OFTHE SEAPS PROJECT . The project is a collaborative plan facilitated by the Pharmaceutical Society of Ghana to integrate the pharmaceutical supply chain through digital technology and fintech to the banking sector.
This is the reason for the project;
In Ghana, the percentage of people with high blood pressure is around 30.3%, and the difference between those living in rural and urban areas is getting smaller. Sixty percent of adult deaths are caused by heart-related diseases. An estimated 6.4% of people have diabetes.
In order to control the rising prevalence of non-communicable diseases in Africa, pharmacies will be extremely important. Access to the right medications can prevent 80% of diabetes, stroke, and early heart disease.
Nonetheless, because of ineffective supply chain management, 60% of pharmacies surveyed experienced stockouts of necessary medications. Retail pharmacies often operate using loans or self-financing, making upfront payment of invoices challenging. A consequence of this is stockouts and payment default.
By utilising a digital platform to link the banking system and the pharmaceutical supply chain, the SEAPS (Strategy for Enhanced Access to Pharmaceutical Services) project seeks to increase access to medications.
The banks provide flexible credit terms for inventory acquired and processed through the platforms inventory systems thereby lower their risk for facility default.
The program supports community pharmacies by enabling banks to negotiate advantageous purchasing agreements, offering flexible credit terms, and helping source high-quality pharmaceuticals affordably.
Analysis of supply chain data to inform management decisions improve access to essential medicines, digitalised services, enhance data accessibility, provide financial support to qualified pharmacists, and reduce procurement costs through group purchasing.
The program also assists young pharmacists in setting up model pharmacies through training, mentorship, and financial aid. am extremely grateful to the President of the Pharmaceutical society of Ghana and his deputy executive secretary for their commitment to see this through.
It has been 4 years of negotiations, disappointments, collaborations, meetings, determination , grit and faith.

THE SILENT EPIDEMIC THAT IS CREEPING ON US...😢

"By 2030, approximately three-quarters of all cancer deaths will occur in LMICs. In addition, most of the projected increase in the global cancer burden in the next 50 years will occur in LMICs. Despite this, cancer research is currently conducted overwhelmingly in high-income countries, with little regard for the limited transferability of knowledge gained in high-income countries to health systems and populations in LMICs.""

Dr Weiderpass and her research colleagues identified the following as priority areas of focus in LMICs: (i) reducing the burden of patients diagnosed with advanced-stage cancers; (ii) improving the access to, affordability of, and outcomes of cancer treatment; (iii) value-based care and health economics; (iv) quality improvement and implementation research; and (v) leveraging technology to improve cancer control.

Priorities for cancer research in low- and middle-income countries: a global perspective In a new article, Dr Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC), and researchers from partner institutions identify five priorities for cancer research in low- and middle-income countries (LMICs), on the basis of current and projected needs. The article....

Here are some of the key takeaways from the recent Global Digital Health Monitor Report:

Analyses global digital health trends based on data from 67 countries across all WHO regions

No country is at Phase 1, indicating growing advancements in digital health across all 67 countries

Most countries (40%) are at Phase 3 of digital health maturity, such as Japan and Namibia. Followed by 33% in Phase 2, for example, Ireland and Morocco. Plus 22% at Phase 4, such as Austria and Brazil

There is a rise in the adoption of emerging technologies like AI and blockchain, but 55% of countries show no progress in readiness for at least one of these technologies

Digital health funding remains insufficient in most countries, with 90% of them meeting only half of countries’ national digital health needs

Over 50% of countries lack digital health-focused training for health professionals

Over half of the 67 countries do not have any mechanism for certifying AI in health applications

Many countries don't have the capability to exchange individuals’ health information seamlessly through the health system

While many countries have digital health systems that help monitor population health, they are not engaging patients to receive feedback

The future focus will be to make digital health fair and effective for everyone. E.g., teaching doctors, pharmacists and nurses how to use digital health tools well or overcoming biases that may be a barrier to adoption

These are going to be the biggest changes in digital health next year.

Let’s get ready for this great collaboration.

Happy new month

We give you the bargaining power! Sign up today.

Happy independence day

Happy new month. Have a good one